Serum pepsinogen as a predictor for gastric cancer death: A 16-year community-based cohort study
Journal of Clinical Gastroenterology Apr 11, 2019
Chiang TH, et al. - The long-term association between initial serum pepsinogen (PG) measurements and subsequent gastric cancer-specific deaths from long-term longitudinal cohort was validated by researchers in this analysis. In order to determine serum PG levels, 1682 (47.9%) were screened among participants (n=3514) aged ≥30 years. Fourteen deaths from gastric cancer were documented after 16 years of follow-up. Multivariate analyses adjusted for age, sex, and Helicobacter pylori serological positivity exhibited that PG-I <30 μg/L and PG-I <30 μg/L or PG-I/II ratio <3 were significantly related to the risk of gastric cancer death. There were, on the other hand, no significant associations between PG and other death causes, including neoplastic and non-neoplastic diseases. This long-term cohort study demonstrates the usefulness of measuring PG as a biomarker specific to the risk of death from gastric cancer.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries